Monte Rosa Therapeutics, Inc.·4

May 22, 4:05 PM ET

Manning Anthony M. 4

4 · Monte Rosa Therapeutics, Inc. · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Monte Rosa (GLUE) Director Anthony Manning Exercises Options, Sells Shares

What Happened
Anthony M. Manning, a director of Monte Rosa Therapeutics (GLUE), exercised stock options and sold shares on 2026-05-21. He exercised 10,000 shares at $4.16 per share (cost = $41,600) and sold 10,000 shares in an open-market transaction at $18.01 per share (proceeds = $180,100). The filing also shows a separate derivative conversion/disposition of 10,000 shares reported at $0.00 consideration; the filing excerpt does not explain that $0.00 entry. Footnotes state the optioned shares were fully vested and exercisable.

Key Details

  • Transaction dates: 2026-05-21 (filed on Form 4: 2026-05-22 — appears timely)
  • Exercise (code M): 10,000 shares at $4.16 → $41,600 total cost
  • Sale (code S): 10,000 shares at $18.01 → $180,100 total proceeds
  • Derivative conversion/disposition: 10,000 shares at $0.00 (reported as disposed; filing does not explain)
  • Shares owned after transaction: not specified in the provided filing excerpt
  • Footnote: the option shares were fully vested and exercisable

Context
This sequence — exercising options and selling shares the same day — is commonly used to realize gains from vested options. The filing shows both an option exercise and an immediate open-market sale; one entry listed at $0.00 may reflect a non-cash settlement or withholding but is not described in the filing excerpt. No 10b5-1 plan, gift, or tax-withholding details are specified in the provided information.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-21$4.16/sh+10,000$41,60010,000 total
  • Sale

    Common Stock

    2026-05-21$18.01/sh10,000$180,1000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1]
    2026-05-2110,00012,100 total
    Exercise: $4.16Exp: 2034-06-12Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option are fully vested and exercisable.
Signature
/s/ Markus Warmuth, Attorney-in-Fact|2026-05-22

Documents

1 file
  • 4
    ownership.xmlPrimary

    4